D.A. Davidson & Co.
- SEC CIK
- 0001080107
- Latest filing
- Jul 24, 2026
NVCR holding history
NovoCure Ltd in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVCR overviewAll 13F holders of NVCRFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −5,940−100.0% | Sold out | Holders |
| Q2 2023 | 5,940 | $246.5K | <0.1% | −2,063−25.8% | Reduced | Holders |
| Q1 2023 | 8,003 | $481.3K | <0.1% | −2,004−20.0% | Reduced | Holders |
| Q4 2022 | 10,007 | $734.0K | <0.1% | −72−0.7% | Reduced | Holders |
| Q3 2022 | 10,079 | $766.0K | <0.1% | +941+10.3% | Added | Holders |
| Q2 2022 | 9,138 | $635.0K | <0.1% | −228−2.4% | Reduced | Holders |
| Q1 2022 | 9,366 | $776.0K | <0.1% | +3,440+58.0% | Added | Holders |
| Q4 2021 | 5,926 | $445.0K | <0.1% | −1,635−21.6% | Reduced | Holders |
| Q3 2021 | 7,561 | $878.0K | <0.1% | +2,501+49.4% | Added | Holders |
| Q2 2021 | 5,060 | $1.12M | <0.1% | +1,436+39.6% | Added | Holders |
| Q1 2021 | 3,624 | $479.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.